Capital Group Private Client Services Inc. acquired a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 6,354 shares of the biopharmaceutical company’s stock, valued at approximately $1,207,000. A number of other […]